Forbes renews major sterol deal with large customer

By staff reporter

- Last updated on GMT

Related tags: Contract, Phytosterol, Sterol, Forbes

Canadian sterol maker Forbes Medi-Tech is seeing sustained demand
for its plant sterols, announcing today the renewal of a major
supply agreement with an unnamed multinational firm.

The contract, for a minimum of US$4.8 million, paid to Forbes' manufacturing joint venture Phyto-Source LP, was originally signed in September 2002.

It was renewed in June 2004 and under the latest extension is effective until the end of 2006.

"The extension of this agreement is an important event for Forbes as it demonstrates the continued demand for our phytosterol ingredients from an established customer,"​ said Charles Butt, president and chief executive of Forbes Medi-Tech.

Forbes recently expanded the capacity for its cholesterol-lowering ingredient to 1500 metric tonnes, anticipating increased demand for the product in Europe especially.

For competitive reasons, the identity of the customer and contractual terms and conditions could not be disclosed, said Forbes.

Related news

Show more

Related products

show more

The Year of

The Year of "Destination Health" Has Arrived

Blue California | 01-Apr-2022 | Infographic

Consumers are pursuing prevention over cure as the ticket to long-term health and wellness. While immunity is at the forefront of health, consumers are...

Related suppliers

Follow us

Products

View more

Webinars